AMERICAN INTERNATIONAL GROUP, INC. - LEXICON PHARMACEUTICALS INC ownership

LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 113 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
AMERICAN INTERNATIONAL GROUP, INC. ownership history of LEXICON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$50,396
-50.6%
46,235
+3.7%
0.00%
-100.0%
Q2 2023$102,113
+4.6%
44,591
+10.9%
0.00%0.0%
Q1 2023$97,669
+29.8%
40,193
+2.0%
0.00%0.0%
Q4 2022$75,241
-20.8%
39,393
-0.4%
0.00%0.0%
Q3 2022$95,000
+50.8%
39,536
+16.0%
0.00%
Q2 2022$63,000
-13.7%
34,092
-1.9%
0.00%
Q1 2022$73,000
-50.3%
34,757
-6.6%
0.00%
-100.0%
Q4 2021$147,000
-17.9%
37,202
+0.1%
0.00%0.0%
Q3 2021$179,000
+2.3%
37,155
-2.3%
0.00%0.0%
Q2 2021$175,000
+2.9%
38,038
+31.2%
0.00%0.0%
Q1 2021$170,000
+107.3%
28,984
+20.8%
0.00%
Q4 2020$82,000
+127.8%
24,000
-2.8%
0.00%
Q3 2020$36,000
-28.0%
24,688
-2.2%
0.00%
Q2 2020$50,000
+4.2%
25,250
+2.8%
0.00%
Q1 2020$48,000
-55.6%
24,569
-5.5%
0.00%
Q4 2019$108,000
+36.7%
25,988
-0.8%
0.00%
Q3 2019$79,000
-52.4%
26,208
-0.7%
0.00%
-100.0%
Q2 2019$166,000
+8.5%
26,390
-4.2%
0.00%0.0%
Q1 2019$153,000
-19.0%
27,556
-3.1%
0.00%0.0%
Q4 2018$189,000
-38.2%
28,449
-0.8%
0.00%0.0%
Q3 2018$306,000
-9.5%
28,669
+1.8%
0.00%0.0%
Q2 2018$338,000
+43.2%
28,151
+2.2%
0.00%0.0%
Q1 2018$236,000
-17.8%
27,546
-5.1%
0.00%0.0%
Q4 2017$287,000
-19.2%
29,028
+0.5%
0.00%0.0%
Q3 2017$355,000
-19.3%
28,891
+8.1%
0.00%
-50.0%
Q2 2017$440,000
+18.0%
26,730
+2.7%
0.00%
+100.0%
Q1 2017$373,000
+11.0%
26,020
+7.1%
0.00%0.0%
Q4 2016$336,000
-99.9%
24,304
-0.3%
0.00%
-50.0%
Q3 2016$440,330,000
+26.1%
24,368
+0.2%
0.00%
+100.0%
Q2 2016$349,150,000
+18.0%
24,331
-1.8%
0.00%0.0%
Q1 2016$296,000,000
-10.3%
24,7810.0%0.00%0.0%
Q4 2015$330,000,000
+124428.3%
24,781
+0.5%
0.00%0.0%
Q3 2015$265,000
-99.9%
24,658
+0.1%
0.00%0.0%
Q2 2015$198,263,00024,6290.00%
Other shareholders
LEXICON PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Ulys, L.L.C. 4,321,214$37,033,000100.00%
Artal Group S.A. 58,274,650$499,413,0006.25%
SECTOR GAMMA AS 854,592$7,324,0001.32%
NEA Management Company, LLC 2,382,286$20,416,0000.91%
Virtus ETF Advisers LLC 89,845$770,0000.67%
Malaga Cove Capital, LLC 59,701$512,0000.28%
MARSHALL WACE, LLP 736,545$6,312,0000.26%
USS Investment Management Ltd 2,741,942$22,607,0000.25%
CLEARBRIDGE, LLC 1,172,117$10,045,0000.22%
WEDBUSH SECURITIES INC 155,396$1,332,0000.17%
View complete list of LEXICON PHARMACEUTICALS INC shareholders